Neuromuscular Symposium

D6802

+ Add to Google Calendar + Add to iCal / Outlook

This Neuromuscular symposium will go over the Neuromuscular topics, which are complicated to handle in the community setting, so that early diagnosis and intervention are realized for appropriate and timely referral to the Neuromuscular experts. Topic areas will be presented by the experts who see these complex patients on a daily basis, and they will be ready to share their expertise with the target audience.

This activity is designed for community physicians in neurology, family medicine and internal medicine. Advanced practice providers, residents, fellows and PA students will also benefit from attending this activity.

Upon completion of the activity, participants should be able to:

• Apply early diagnosis and intervention by timely referral to neuromuscular expert.
• Discuss a stepwise approach to a patient presenting with a nerve or muscle-related neurological complaint.

• 8 a.m. | Symposium Introduction/Opening Remarks
  Zachary Simmons, MD
• 8:15 a.m. | Doctor, I Can’t Talk!: The Clinician’s Approach to Bulbar Weakness
  James Grogan, MD, MS
  • Identify symptoms of bulbar dysfunction and a corresponding differential diagnosis.
  • Describe appropriate diagnostic techniques such as MRI and EMG to guide their diagnosis.
  • Implement strategies for symptomatic management and risk mitigation for patients with dysfunctions of bulbar musculature.
• 9 a.m. | Updates on Myasthenia Gravis and the Impact of COVID on Myasthenia
  Sankar Bandyopadhyay, MD, FAAN
  • Recognize the recent developments and research on myasthenia gravis.
  • Describe the impact of the COVID pandemic on the patients and providers dealing with myasthenia.
• 9:45 a.m. | Approach to a Patient with HyperCKemia and Proximal Muscle Weakness
  Mansoureh Mamarabadi, MD
  • Explain how to approach a patient with elevated creatine kinase (CK).
  • Review differential diagnosis of hyperCkemia and proximal muscle weakness.
  • Discuss factors that can affect CK levels.
• 10:30 a.m. | Break/Visit Virtual Exhibits
• 11 a.m. | Approach to a Patient with Burning Feet
  Max Ricardo Lowden, MD, MEd, FAAN
  • Review the etiology of small fiber neuropathy.
  • Discuss the diagnostics tests used for evaluating small fiber neuropathy.
• 11:45 a.m. | Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and their Variants – A Clinical Update
  Xiaowei Su, MD, PhD
  • Review updated diagnostic considerations for GBS & CIDP including atypical variants.
  • Explain treatment guidelines for GBS & CIDP including refractory cases.
• 12:30 p.m. | Closing Remarks
  Divpreet Kaur, MD

Divpreet Kaur, MD
Assistant Professor, Department of Neurology
Chief, Division of Neuromuscular Medicine
Neurophysiology (EMG) Lab Director
Penn State Health Milton S. Hershey Medical Center

Sankar Bandyopadhyay, MD, FAAN
Associate Professor and Associate Vice Chair for Wellness, Department of Neurology
Division of Neuromuscular Medicine
Penn State Health Milton S. Hershey Medical Center

James Grogan, MD, MS
Assistant Professor, Department of Neurology
Division of Neuromuscular Medicine
Penn State Health Milton S. Hershey Medical Center

Max Ricardo Lowden, MD, MEd, FAAN
Associate Professor
Residency Program Director
Vice Chair for Education, Department of Neurology
Division of Neuromuscular Medicine
Penn State Health Milton S. Hershey Medical Center

Mansoureh Mamarabadi, MD
Assistant Professor, Department of Neurology
Division of Neuromuscular Medicine
Penn State Health Milton S. Hershey Medical Center

Zachary Simmons, MD
Professor and Vice Chair for Research, Department of Neurology
Division of Neuromuscular Medicine
Penn State Neuroscience Institute
Penn State Health Milton S. Hershey Medical Center

Xiaowei Su, MD, PhD
Assistant Professor, Department of Neurology
Division of Neuromuscular Medicine
Penn State Health Milton S. Hershey Medical Center

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Fee is $45 per person and includes the cost of instruction and online handout materials.

No fee for fellows, residents, students and neurophysiology technologists. Send verification of student and technologist status to ContinuingEd@pennstatehealth.psu.edu or fax 717-531-5604.

Payment is required at the time of registration. If you have any questions or concerns, please email ContinuingEd@pennstatehealth.psu.edu.

Registrations received after Monday, March 7, 2022, will incur a $25 late fee.

Cancellations received after Tuesday, March 1, 2022, will be assessed a $25 processing fee.

No refunds will be made for cancellations received after Saturday, March 5, 2022.

A completed evaluation is required in order to receive a certificate for attending this activity. Please complete and submit the evaluation within the specified time frame.

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund any program registration fees paid but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies.

Program registrants who are experiencing illness or have been exposed to anyone who is ill should contact the Continuing Education office before attending any in-person activities.

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

On-campus educational activities provided by Penn State College of Medicine Continuing Education are required to follow healthcare facility guidelines. Off-campus events provided by Penn State College of Medicine Continuing Education follow the COVID-19 requirements of that venue. We ask that all participants respect that some attendees may still choose to wear masks for activities. Check the venue website for the latest requirements and recommendations. Please do not attend this activity if you have symptoms or have been exposed to someone with COVID-19. By attending the activity, you attest that you do not have any symptoms suggestive of COVID-19, which may include fever, cough, shortness of breath, sore throat, loss of taste, loss of smell or any other sign of illness.

Penn State encourages people with disabilities to participate in its programs and activities. Participants who anticipate needing any type of special accommodation or who have questions about the physical access provided should contact the Continuing Education office at least one week in advance of participation or visit.

It is Penn State policy to ensure balance, independence, objectivity and scientific rigor in all educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to mitigate any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission and employment without regard to personal characteristics not related to ability, performance or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment or retaliation against faculty, staff or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; 814-863-0471 (TTY). US M.Ed. D6802